Open Access

Epigenetic silencing of miR-335 and its host gene MEST in hepatocellular carcinoma

  • Authors:
    • Osamu Dohi
    • Kohichiroh Yasui
    • Yasuyuki Gen
    • Hisashi Takada
    • Mio Endo
    • Kazuhiro Tsuji
    • Chika Konishi
    • Nobuhisa Yamada
    • Hironori Mitsuyoshi
    • Nobuaki Yagi
    • Yuji Naito
    • Shinji Tanaka
    • Shigeki Arii
    • Toshikazu Yoshikawa
  • View Affiliations

  • Published online on: November 30, 2012     https://doi.org/10.3892/ijo.2012.1724
  • Pages: 411-418
  • Copyright: © Dohi et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that function as endogenous silencers of target genes. Some tumor-suppressive miRNAs are known to be epigenetically silenced by promoter DNA methylation in cancer. In the present study, we aimed to identify miRNA genes that are silenced by DNA hypermethylation in hepatocellular carcinoma (HCC). We screened for miRNA genes with promoter DNA hypermethylation using a genome-wide methylation microarray analysis in HCC cells. It was found that miR-335, which is harbored within an intron of its protein-coding host gene, MEST, was downregulated by aberrant promoter hypermethylation via further methylation assays, including methylation-specific PCR, combined bisulfite and restriction analysis, bisulfite sequencing analysis and 5-aza-2'-deoxycytidine treatment. The expression levels of miR-335 significantly correlated with those of MEST, supporting the notion that the intronic miR-335 is co-expressed with its host gene. The levels of miR-335/MEST methylation were significantly higher in 18 (90%) out of 20 primary HCC tumors, compared to their non-tumor tissue counterparts (P<0.001). The expression levels of miR-335 were significantly lower in 25 (78%) out of 32 primary HCC tumors, compared to their non-tumor tissue counterparts (P=0.001). Furthermore, the expression levels of miR-335 were significantly lower in HCC tumors with distant metastasis compared to those without distant metastasis (P=0.02). In conclusion, our results indicate that expression of miR-335 is reduced by aberrant DNA methylation in HCC.
View Figures
View References

Related Articles

Journal Cover

February 2013
Volume 42 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Dohi, O., Yasui, K., Gen, Y., Takada, H., Endo, M., Tsuji, K. ... Yoshikawa, T. (2013). Epigenetic silencing of miR-335 and its host gene MEST in hepatocellular carcinoma. International Journal of Oncology, 42, 411-418. https://doi.org/10.3892/ijo.2012.1724
MLA
Dohi, O., Yasui, K., Gen, Y., Takada, H., Endo, M., Tsuji, K., Konishi, C., Yamada, N., Mitsuyoshi, H., Yagi, N., Naito, Y., Tanaka, S., Arii, S., Yoshikawa, T."Epigenetic silencing of miR-335 and its host gene MEST in hepatocellular carcinoma". International Journal of Oncology 42.2 (2013): 411-418.
Chicago
Dohi, O., Yasui, K., Gen, Y., Takada, H., Endo, M., Tsuji, K., Konishi, C., Yamada, N., Mitsuyoshi, H., Yagi, N., Naito, Y., Tanaka, S., Arii, S., Yoshikawa, T."Epigenetic silencing of miR-335 and its host gene MEST in hepatocellular carcinoma". International Journal of Oncology 42, no. 2 (2013): 411-418. https://doi.org/10.3892/ijo.2012.1724